🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Andrew Lindsley

Amgen (United States)

ORCID: 0000-0003-2670-704X
MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study”.

Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study

Advances in Therapy(2024)10.1007/s12325-024-02889-8
N/A
0.713DataRank · unranked
22 citations

Wendy C. Moore, Monica Kraft, Guy Brusselle, Mario Castro, Geoffrey Chupp +8 more

KMT2C/D COMPASS complex-associated diseases [KCDCOM-ADs]: an emerging class of congenital regulopathies

Clinical Epigenetics(2020)10.1186/s13148-019-0802-2
N/A
0DataRank · unranked
98 citations

Artem Barski, Susan Wiley, Elizabeth K. Schorry, Andrew Lindsley, William J. Lavery

EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA AND ALLERGIC RHINITIS GROUPED BY BASELINE BLOOD EOSINOPHIL COUNT: POOLED ANALYSIS OF PATHWAY AND NAVIGATOR

CHEST Journal(2024)10.1016/j.chest.2024.06.2821
N/A
0DataRank · unranked
0 citations

GEOFFREY L CHUPP, Elliot Israel, Mario Castro, Magdalena Bober, Andrew Lindsley +3 more